Medical Device News Magazine

Barbara Moorhouse Appointed as Medica Non-Executive Director

About Medical Device News Magazine

About Medical Device News Magazine. We are a digital publication founded in 2008 located in the United States.

Advertise with Medical Device News Magazine! Join Our #1 Family of Advertisers!

We pride ourselves on being the best-kept secret when it comes to distributing your news! Our unique digital approach enables us to circulate your...

Barbara Moorhouse will join the Board of Medica as a Non-Executive Director on 1 July 2021. Medica is the market leader in the UK and Ireland for the provision of teleradiology services, providing outsourced interpretation and reporting of MRI (magnetic resonance imaging), CT (computerized tomography), ultrasound, and plain film (x-ray) images. Medica also offers diabetic retinopathy screening in Ireland.

Barbara Moorhouse will serve as the Senior Independent Director and Chair of the Audit Committee. As previously announced, Steve Whittern, Senior Independent Non-Executive Director and Chair of the Audit Committee, will stand down from the Board ahead of the Annual General Meeting on 16 June 2021.

Barbara has extensive business and management experience in the private, public, and regulated sectors. In the private sector, Barbara has held a series of strategic, commercial, and finance roles, including being Chief Finance Officer for two international listed IT companies – Kewill Systems plc and Scala Business Solutions NV, Group Finance Director at Morgan Sindall plc, and Regulatory Director at South West Water.

In the public sector, she has been Director General at the Ministry of Justice and the Department for Transport and Chief Operating Officer at Westminster City Council. Barbara has been a Trustee and Chair of the Audit Committee for Guy’s & St Thomas’ Charity and a Non-Executive Director of the NHS West Hampshire Clinical Commissioning Group. She is Non-Executive Director at Balfour Beatty plc, Non-Executive Director and Chair of the Audit Committee at Aptitude Software Group plc and Chair of the Rail Safety & Standards Board. Barbara is currently Non-Executive Director at Agility Trains (East) Ltd but is stepping down this month having been on the board since 2015.

Roy Davis, Chairman of Medica, said: “We are delighted to have someone of Barbara’s expertise and stature join the Board of Medica. Barbara is a seasoned Non-Executive Director and brings significant experience from both the private and public sectors. Coupled with her extensive background in the most senior of finance positions in large scale, highly complex, and fast-growing organizations, Barbara will further strengthen Medica’s Board. I very much look forward to working with her.”

Commenting on her appointment, Barbara Moorhouse added: “I am very pleased to be joining the Board of such an exciting and rapidly-growing company with a compelling strategy in place. I am looking forward to engaging with the Board and the management team and using my expertise to help implement this strategy.”

 

Medical Device News Magazinehttps://infomeddnews.com
Medical Device News Magazine provides breaking medical device / biotechnology news. Our subscribers include medical specialists, device industry executives, investors, and other allied health professionals, as well as patients who are interested in researching various medical devices. We hope you find value in our easy-to-read publication and its overall objectives! Medical Device News Magazine is a division of PTM Healthcare Marketing, Inc. Pauline T. Mayer is the managing editor.

Other News

Shoulder Innovations Further Strengthens IP Portfolio in Key Areas with Recent Patent Grants

"These recent grants further strengthen key patent families that are foundational to our technology, and we are pleased the USPTO continues to recognize our meaningful innovation in the shoulder arthroplasty segment," said Rob Ball, CEO of Shoulder Innovations. "This noteworthy expansion of our IP position represents the culmination of over 10 years of research and development, and we are proud of our team for their continued dedication to creating practical solutions for shoulder surgeons and advancing patient outcomes."

Radical Catheter Technologies Presents Analysis of Disruptive, Recently FDA-Cleared Endovascular Technology at the Society of NeuroInterventional Surgery 21st Annual Meeting

This new catheter, the first product commercialized from this novel technology platform, is designed to enable access to the blood vessels in the brain for both femoral and radial access. A multi-center analysis of this disruptive technology is being presented today at Society of NeuroInterventional Surgery 21st annual meeting. In addition, the Company confirmed the closing of a $20 million financing round led by NeuroTechnology Investors, which will be used to scale the company and expand the Radical platform notes Radical Catheter Technologies.

Rapid Medical™ Completes Initial Neurovascular Cases in the USA Following FDA Clearance of Its Active Access Solution

“With DRIVEWIRE, our design goal was to bring new levels of access and control to the interventional suite while improving best-in-class guidewires,” comments Giora Kornblau, Chief Technology Officer at Rapid Medical. “When physicians are looking for technologies that increase the clinical possibilities and safety for the patient, we want Rapid to be the first place they look.”